The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Methyl 4-[(4-oxo-2-phenyl-3,5,7,8-tetrahydropyrido[4,3-d]pyrimidin-6(4H)-yl)carbonyl]benzoate ID: ALA4453480
PubChem CID: 155523113
Max Phase: Preclinical
Molecular Formula: C22H19N3O4
Molecular Weight: 389.41
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)c1ccc(C(=O)N2CCc3nc(-c4ccccc4)[nH]c(=O)c3C2)cc1
Standard InChI: InChI=1S/C22H19N3O4/c1-29-22(28)16-9-7-15(8-10-16)21(27)25-12-11-18-17(13-25)20(26)24-19(23-18)14-5-3-2-4-6-14/h2-10H,11-13H2,1H3,(H,23,24,26)
Standard InChI Key: IIFXOEHKSRCLRR-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
26.5078 -20.5164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5066 -21.3360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2147 -21.7449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9243 -21.3355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9215 -20.5128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2129 -20.1076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6277 -20.1016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3342 -20.5097 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.3304 -18.8763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6201 -19.2858 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.3301 -18.0591 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.0394 -19.2844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0379 -20.1039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7429 -20.5127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4540 -20.1065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4555 -19.2870 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.7460 -18.8737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1644 -18.8805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8709 -19.2911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1667 -18.0633 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.8642 -20.1089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5699 -20.5194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5731 -18.8846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2794 -19.2914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2761 -20.1094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9834 -20.5185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9828 -21.3357 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.6915 -20.1105 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.3989 -20.5197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 2 0
7 10 1 0
8 13 1 0
12 9 1 0
9 10 1 0
9 11 2 0
12 13 2 0
12 17 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
16 18 1 0
18 19 1 0
18 20 2 0
19 21 2 0
21 22 1 0
22 25 2 0
24 23 2 0
23 19 1 0
24 25 1 0
25 26 1 0
26 27 2 0
26 28 1 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 389.41Molecular Weight (Monoisotopic): 389.1376AlogP: 2.42#Rotatable Bonds: 3Polar Surface Area: 92.36Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.98CX Basic pKa: 0.65CX LogP: 1.99CX LogD: 1.90Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.69Np Likeness Score: -1.19
References 1. Kawai J, Ota M, Ohki H, Toki T, Suzuki M, Shimada T, Matsui S, Inoue H, Sugihara C, Matsuhashi N, Matsui Y, Takaishi S, Nakayama K.. (2019) Structure-Based Design and Synthesis of an Isozyme-Selective MTHFD2 Inhibitor with a Tricyclic Coumarin Scaffold., 10 (6): [PMID:31223444 ] [10.1021/acsmedchemlett.9b00069 ] 2. Eadsforth, Thomas C and 13 more authors. 2015-10-22 Characterization of 2,4-Diamino-6-oxo-1,6-dihydropyrimidin-5-yl Ureido Based Inhibitors of Trypanosoma brucei FolD and Testing for Antiparasitic Activity. [PMID:26322631 ]